Popular Articles
Burdock Root

Fighting Tuberculosis With Anti-inflammatory Drugs Shown Possible In Animal Studies
Tuberculosis (TB) experts at Johns Hopkins have evidence from a four-year series of experiments in mice that anti-inflammatory drugs could eventually prove effective in treating the highly contagious lung disease, adding to current antibiotic therapies.
generic viagra online
Novocell Obtains U.S. Patent For Drug Screening Human Embryonic Cell Derived-Endoderm Cells
Novocell, Inc., a stem cell engineering company, announced that it has received U.S. Patent No. 7,541,185 with method claims covering the use of endoderm cells derived from human embryonic stem cells (hESCs) for drug discovery. This is the second U.S. patent issued to Novocell related to human endoderm. U.S. Patent No. 7,510,876, issued on March 31, 2009, is directed to an in vitro human endoderm composition.
News of the day
Single-payer Advocates Challenge Democrats While Private Insurers Get Nervous
Democrats working feverishly on health care reform "face increasingly noisy protests from those on the left who complain that a national program like those in Europe has been excluded from the debate," The Washington Post reports.
Public Health

ProspectIP Has Agreed Licensing Deals For Two Inventors And Products, A Device That Aims To Prevent (DVT) And A Safety Opener For Glass Vials, UK

A University initiative to commercialise novel business ideas and inventions has secured its first two licensing agreements and attracted a further ÷£400,000 in funding. De Montfort University (DMU), Leicester, set up ProspectIP following a ÷£2 million pilot funding award from the Higher Education Funding Council for England (HEFCE) in 2006. The project has already resulted in the launch of new products under direct contracts with entrepreneurs. Now ProspectIP has agreed licensing deals for two inventors and their products, a device that aims to prevent Deep Vein Thrombosis (DVT) and a safety opener for glass vials. The University has also secured ÷£400,000 from the European Regional Development Fund to help support the scheme for the next two and a half years. The licensing deals for both products have been agreed with British company Wallace Cameron Ltd. Based in Wishaw near Glasgow, the company provides first aid solutions for the travel, home and leisure industries and has established links with the healthcare, medical and consumer markets. Inventor Noel McKenzie worked with ProspectIP to develop the Under-Foot Oscillator (U-FO) which aims to prevent Deep Vein Thrombosis in people seated for long periods of time by ensuring sufficient movement of blood up the legs. The U-FO is a compact elliptical rocking device which can also be used to store complementary products such as compression socks. It is currently undergoing clinical testing. Dr Anant Ghelani approached DMU to help with his invention for the safe opening of glass vials, widely used to store small amounts of medicines, drugs and other chemicals. It is hoped the portable device could become part of the kit of any doctor, nurse or scientist to help reduce shattering accidents in hospitals and laboratories. DMU experts created a commercialisation strategy for each product, working with the inventors on issues such as intellectual property, prototyping and market analysis before identifying and negotiating with the best licence partner. Under the licensing agreements Wallace Cameron has exclusive rights to manufacture, distribute and sell the two products worldwide. The inventors will receive royalties on sales of the products. Both inventions are expected to be on sale in late 2009. Derek Palmer, Head of ProspectIP at DMU, said: "We are delighted to secure licence agreements for these inventors. Wallace Cameron is the ideal partner with the contacts and experience to help these products reach their full potential. "The invention process is long and complex and many great business ideas don"t progress because of a lack of expertise, investment or fragmented support. We help develop latent intellectual property and boost economic activity by supporting inventors through the whole commercialisation process." Giovanni Benedetti, Group Chairman of Benedetti International Ltd, the holding company of Wallace Cameron, said: "Our product design division is delighted to work in conjunction with DMU and both inventors. The combination of DMU, the re facilities of Benedetti International, shared product knowledge, innovative design and Wallace Cameron"s network of sales and marketing re will lead to a successful commercial launch of these new products. "Our aim is to work further with universities and inventors to bring a strong commercial element to academics and enable commercial success for idea and inventions, so we can offer a large and varied range of products. I"m certain this initial collaboration will be the start of many similar joint ventures between us and DMU." De Montfort University


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):